TBF1.F - Canntab Therapeutics Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2019-05-31
2018-05-31
2017-12-31
2017-05-31
2016-12-31
Cash flows from operating activities
Net Income
-2,282
-2,459
-2,408
-182.447
-1,116
519.777
Depreciation & amortization
189.13
80.609
51.482
-
1.615
-
Stock based compensation
245.861
402.369
319.938
0
681.6
50.75
Change in working capital
377.735
-317.459
107.952
73.188
78.23
-127.956
Accounts receivable
185.166
-69.741
-129.324
-0.288
19.51
-8.174
Other working capital
-2,426
-2,651
-1,468
-114.813
-454.38
-408.929
Other non-cash items
-118.333
-39.999
660.293
-
-
-
Net cash provided by operating activites
-1,588
-2,333
-1,269
-114.813
-354.807
-408.929
Cash flows from investing activities
Investments in property, plant and equipment
-838.131
-317.714
-199.063
-
-99.573
-
Net cash used for investing activites
936.869
2,007
-199.063
0
-99.573
1,166
Cash flows from financing activities
Common stock issued
1,708
0
5,008
100
1,413
-
Other financing activites
-
-
-480.615
-
-
-851.854
Net cash used privided by (used for) financing activities
1,494
21.9
4,727
100
1,413
-851.854
Net change in cash
843.53
-303.872
3,259
-14.813
958.62
-95.131
Cash at beginning of period
653.193
717.85
958.62
15.562
0
110.693
Cash at end of period
1,497
413.978
4,218
0.749
958.62
15.562
Free Cash Flow
Operating Cash Flow
-1,588
-2,333
-1,269
-114.813
-354.807
-408.929
Capital Expenditure
-838.131
-317.714
-199.063
-
-99.573
-
Free Cash Flow
-2,426
-2,651
-1,468
-114.813
-454.38
-408.929